Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced the closing of its initial public offering of 3,263,010 ordinary shares at a public offering price of $13.50 per share, which included 425,610 ordinary shares issued upon the exercise in full of the underwriters’ option to purchase additional ordinary shares to cover over-allotments. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock performance was -1.58% in last session and finished the day at $10.93. … Continue reading Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

Biotech Most Volatile: Marina Biotech (OTCMKTS:MRNA), Onconova Therapeutics (NASDAQ:ONTX), OXiGENE Inc (NASDAQ:OXGN), Oragenics Inc (NYSEMKT:OGEN)

Marina Biotech, Inc. (OTCMKTS:MRNA) illustrated a similar run of events, as it reinvigorated its PR activity in the new year and shot upwards as it received a patent protection for one of its therapies. MRNA is back at $1.38, after it slumped for a while following a temporary peak at $1.70. Marina Biotech, Inc. (OTCMKTS:MRNA) stock performance was 16.67% in last session and finished the … Continue reading Biotech Most Volatile: Marina Biotech (OTCMKTS:MRNA), Onconova Therapeutics (NASDAQ:ONTX), OXiGENE Inc (NASDAQ:OXGN), Oragenics Inc (NYSEMKT:OGEN)

Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Ocera Therapeutics (NASDAQ:OCRX), Onconova Therapeutics (NASDAQ:ONTX), CYANOTECH (NASDAQ:CYAN)

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the healthcare company since Feb 24, as the stock is now down nearly 19%.stock performance was -7.00% in last session and finished the … Continue reading Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Ocera Therapeutics (NASDAQ:OCRX), Onconova Therapeutics (NASDAQ:ONTX), CYANOTECH (NASDAQ:CYAN)

Hot Alert : API Technologies Corp. (NASDAQ:ATNY), InvenSense, Inc. (NYSE:INVN), FireEye, Inc. (NASDAQ:FEYE), Onconova Therapeutics, Inc. (NASDAQ:ONTX), Google Inc (NASDAQ:GOOGL)

API Technologies Corp (NASDAQ:ATNY) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a research note issued on Wednesday. The firm currently has a $2.30 price target on the stock. Zacks‘s price objective suggests a potential upside of 2.22% from the stock’s previous close. API Technologies Corp. (NASDAQ:ATNY) belongs to Technology sector. Its net profit margin is -7.90% and weekly performance is -3.49%. On … Continue reading Hot Alert : API Technologies Corp. (NASDAQ:ATNY), InvenSense, Inc. (NYSE:INVN), FireEye, Inc. (NASDAQ:FEYE), Onconova Therapeutics, Inc. (NASDAQ:ONTX), Google Inc (NASDAQ:GOOGL)

Top Stories : Onconova Therapeutics (NASDAQ:ONTX), Comcast (NASDAQ:CMCSA), Salix Pharmaceuticals (NASDAQ:SLXP), Radio One Inc. (NASDAQ:ROIA), W&T Offshore (NYSE:WTI)

Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today provided a corporate update and reported financial results for the second quarter ended June 30, 2014. Onconova Therapeutics, Inc. (NASDAQ:ONTX) belongs to Healthcare sector. Its weekly performance is 5.50%. On last trading day company shares ended up $5.37. Onconova Therapeutics, Inc. (NASDAQ:ONTX) distance from 50-day simple … Continue reading Top Stories : Onconova Therapeutics (NASDAQ:ONTX), Comcast (NASDAQ:CMCSA), Salix Pharmaceuticals (NASDAQ:SLXP), Radio One Inc. (NASDAQ:ROIA), W&T Offshore (NYSE:WTI)

Biotech Gainers: Ignyta Inc (NASDAQ:RXDX), Onconova Therapeutics Inc (NASDAQ:ONTX), Cempra Inc (NASDAQ:CEMP), ANI Pharmaceuticals Inc (NASDAQ:ANIP)

Ignyta Inc (NASDAQ:RXDX) released its earnings data. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.37) by $0.09. Finally, analysts at Ladenburg Thalmann initiated coverage on shares of company in a research note on Monday, March 24th. They set a “buy” rating and a $20.00 price target on the stock. Ignyta Inc (NASDAQ:RXDX) stock performance was 13.12% … Continue reading Biotech Gainers: Ignyta Inc (NASDAQ:RXDX), Onconova Therapeutics Inc (NASDAQ:ONTX), Cempra Inc (NASDAQ:CEMP), ANI Pharmaceuticals Inc (NASDAQ:ANIP)